– Company seeks proposals to create and sustain community-focused programs to support underserved populations with these conditions – VICTORIA, British Columbia & ROCKVILLE, Md.--(BUSINESS WIRE)--Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) (Aurinia o
Additions of Venkat Ramanan, Ph.D., as Chief Financial Officer and P. Joseph Campisi Jr., J.D., M.B.A., as General Counsel, serve to strengthen the financial, legal and business operations within the Company NEW YORK--(BUSINESS WIRE)--#TIL--Turnstone B
Merger transaction follows a fully funded $160 million investment in Lygos to accelerate integration and scale production to meet increasing demand for agricultural, industrial, and consumer applications BERKELEY, Calif. & VICTORIA, British Columbia--(BU
YONGIN, South Korea--(BUSINESS WIRE)--GC Biopharma (006280.KS), a South Korean biopharmaceutical company, takes part in a campaign to celebrate World Hemophilia Day. Started in 1989 by the World Federation of Hemophilia (WFH) in honor of their founder Fr
CHARLOTTETOWN, Prince Edward Island--(BUSINESS WIRE)--BIOVECTRA broke ground today, with help from provincial and federal officials, on a cutting-edge facility that will manufacture mRNA vaccines and therapeutics starting in 2023. BIOVECTRA’s mRNA Vacc
VICTORIA, British Columbia--(BUSINESS WIRE)--$IPA #AI--IPA (IMMUNOPRECISE ANTIBODIES LTD.) (the “Company” or “IPA”) (NASDAQ: IPA) (TSXV: IPA) is pleased to announce that it has completed its previously announced acquisition of control over BioStra
ST. JACOBS, Ontario--(BUSINESS WIRE)--Huron Digital Pathology, a global leader in digital pathology innovation, today announced that it has appointed Audil Virk, BSc, as President, effective April 12, 2022. Mr. Virk has more than 15 years of senior manag
VANCOUVER, British Columbia--(BUSINESS WIRE)--Eat Well Investment Group Inc. (CSE: EWG) (US:EWGFF) (FSE: 6BC0) (“Eat Well” or the “Company”) is providing an update with respect to its previously announced management cease trade order (“MCTO”)
WESTWOOD, Mass.--(BUSINESS WIRE)--Fraser Health (Surrey, B.C.) has selected MEDITECH Expanse to transform care and promote better health outcomes for the more than 1.9 million people it serves throughout 20 diverse communities. The system’s mobile tech
- Delivery of CYB004 via inhalation showed significant advantages over intravenously administered dimethyltryptamine (“IV DMT”) in preclinical studies - -- Rapid onset, longer duration of action and similar low variability achieved with single inhal
Sign up for one of BAM's newsletter to learn more about bioscience, happenings in Manitoba's bioeconomy, industry conferences, and BAM training events.